Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3913233 | 0.87 | AR (0.47) | MAOAMAOB | |
| SCHEMBL3920848 | 0.86 | — | — | |
| SCHEMBL3913226 | 0.85 | SLC6A4 (0.51) | ALDH1A1TSHR | |
| SCHEMBL11452110 | 0.84 | KCNA3 (0.65) | PKML3MBTL1ALDH1A1TSHRNPC1 | |
| SCHEMBL3912910 | 0.82 | SLC6A4 (0.49) | L3MBTL1ALDH1A1TSHR | |
| Trifluoroacetic Acid SCHEMBL3909784 | 0.81 | AR (0.47) | ALDH1A1MAOAMAOB | |
| Trifluoroacetic Acid SCHEMBL3918872 | 0.81 | MRGPRX4 (0.44) | — | |
| Trifluoroacetic Acid SCHEMBL3923215 | 0.80 | LRRK2 (0.44) | — | |
| SCHEMBL16527515 | 0.80 | MAOB (0.50) | NPC1MAOAMAOBRAB9A | |
| SCHEMBL3915228 | 0.78 | KCNA3 (0.47) | ALDH1A1TSHRMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7538233-B2 | Coumarins as iNOS inhibitors | AVENTIS PHARMACEUTICALS INC. (US) | 2009-05-26 | — | — | US | disclosed |
| US-7538233-B2 | Coumarins as iNOS inhibitors | AVENTIS PHARMACEUTICALS INC. (US) | 2009-05-26 | — | — | US | disclosed |